Revenue: The sum of all revenue fields included for a company's operating activities.
BioNTech SE Sponsored ADR (BNTX) had Revenue of $192.58M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
|
Revenue |
$192.58M |
$-438.05M |
|
$88.28M |
|
$104.30M |
|
$755.25M |
|
$-562.67M |
|
$93.45M |
|
$-469.23M |
|
$-469.23M |
|
$-438.05M |
|
$-438.05M |
|
$-438.05M |
|
$-438.05M |
|
$-562.67M |
|
$-517.58M |
|
240.35M |
|
240.35M |
|
$-1.82 |
|
$-1.82 |
|
| Balance Sheet Financials | |
$16.46B |
|
$1.08B |
|
$5.85B |
|
$22.32B |
|
$1.62B |
|
$250.21M |
|
$759.89M |
|
$2.38B |
|
$19.94B |
|
$17.95B |
|
$19.94B |
|
240.39M |
|
| Cash Flow Statement Financials | |
$-822.47M |
|
$1.31B |
|
$-14.54M |
|
$10.28B |
|
$10.73B |
|
$445.63M |
|
$19.49M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
10.18 |
|
-- |
|
-- |
|
0.01 |
|
0.02 |
|
54.16% |
|
-292.18% |
|
-292.18% |
|
-- |
|
-243.65% |
|
-227.46% |
|
$-873.46M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.33 |
|
0.18 |
|
500.71 |
|
-2.20% |
|
-2.44% |
|
-1.96% |
|
-2.17% |
|
$82.94 |
|
$-3.63 |
|
$-3.42 |
|